|
Companies
|
|
Friday, 30 July 2010 |
|
Alcon reported that global sales rose 12.5 percent to US$1.89 billion for the second quarter of 2010, or 11.3 percent excluding the impact of foreign exchange fluctuations and acquisitions. Revenue from acquisitions added 40 basis points to sales growth in the quarter, while foreign currency fluctuations added 80 basis points of growth.
Net earnings for the second quarter of 2010 grew 15.1 percent to US$670 million, or US$2.21 per diluted share, compared to US$582 million, or US$1.94 per diluted share in the second quarter of 2009. Non-GAAP adjusted net earnings would have grown 15.8 percent to US$674 million, or US$2.22 per diluted share, compared to second quarter 2009 net earnings.
Adjusted net earnings in the second quarter of 2010 exclude US$4 million in other operating expenses related to the potential change of control and merger proposal from Novartis AG.
|
